Johnson & Johnson's Imbruvica Scores Expanded FDA Approval for Chronic Graft vs Host Disease Post author:Sam Post published:August 2, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like <b>Jaguar Health Company</b> Name Now Updated On Nasdaq.com Post-Merger August 15, 2017 Meet the Scientist Who Admits His MS Therapy is 'Largely Ineffective.' November 28, 2017 How Gilead's $12 Billion Kite Pharma Deal Has Already Paid Off for Investors September 18, 2017